KABBEEK FARMA
ActiveSummary
KABBEEK FARMA has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €421,604 and a net result of €158,596. Equity has been growing by about 17% per year since 2018. Its solvency ranks better than 68% of 9,537 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.7% (low).
Overview
Official details
Source: KBO- Status
- Active since 14-03-2003 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2021
- Establishment unit
- 2.229.750.975 3300 Tienen, since 07-03-2003
- Financial year end
- 31 December
- Peppol
- Reachable
Board and ownership
- Farma VitasDirector · permanent representative AMATO,Bruno Salvatore Albert
- Farma Vitas100%31-03-2025 annual accounts of Farma Vitas
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.7%
- Gross margin
- €289,189
- ▲ 20.5%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €158,596
- ▲ 33.2%
- Equity
- €421,604
- ▲ 17.8%
- Total assets
- €763,791
- ▲ 10.8%
- Employees on 31-12-2024
- 1
- =
- 2025 accounts not filed, 96 days past the deadline
Score breakdownraises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed on 29-05-2025)lowers riskFounded in 2003Equity €421,604 (55.2% of total assets)Size: 0.8 FTE, total assets €763,791Show the evidence
Checked score
About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 69% of them on solvency, 44% on liquidity, 88% on profitability and 70% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 6 accounts on average 40 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
Key points
Recent changes
- · Gazette deed 1 director resigning, 1 reappointedResignation: FARMA VITAS (manager) · Reappointment: FARMA VITAS (director) · Permanent representative: AMATO,Bruno Salvatore Albert
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as KABBEEK FARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €675,000 and €908,000, founded between 1997 and 2007.
| Company | Total assets | Gross margin |
|---|---|---|
| KABBEEK FARMA Tienen | €763,791 | €289,189 |
| Apotheek Schuttershof Scherpenheuvel-Zichem | €849,063 | €228,530 |
| APOTHEEK CHANTAL GALMART Sint-Pieters-Leeuw | €736,487 | €231,868 |
| Apotheek Schoonderbuken Scherpenheuvel-Zichem | €736,532 | €247,063 |
| NOVIL'PHARMA Fernelmont | €907,966 | €304,100 |
| FINANCIERE DELHAYE Vorst | €674,523 | €277,166 |
| Apotheek Verstraete Izegem Izegem | €846,479 | €312,371 |
Key facts about KABBEEK FARMA
- What is the company number of KABBEEK FARMA?
- The company number of KABBEEK FARMA is 0479.774.272. The VAT number is the same number with BE in front: BE 0479.774.272.
- Where is KABBEEK FARMA based?
- The registered office is at Diestsesteenweg 9, 3300 Tienen.Company details
- What does KABBEEK FARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of KABBEEK FARMA?
- The legal form of KABBEEK FARMA is Private limited company (BV).
- When was KABBEEK FARMA founded?
- KABBEEK FARMA was founded on 14-03-2003.
- Is KABBEEK FARMA still active?
- Yes, KABBEEK FARMA is an active enterprise in the KBO register.
- How many employees does KABBEEK FARMA have?
- KABBEEK FARMA had an average of 0.8 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- Which joint committee does KABBEEK FARMA fall under?
- In its 2021 annual accounts, KABBEEK FARMA states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of KABBEEK FARMA?
- The turnover in financial year 2024 is ≈ €1.1m. This figure is estimated from the gross margin of €289,189 and 47 comparable companies (NACE 477). It probably lies between €820,000 and €1.7m.
- Is KABBEEK FARMA profitable?
- In financial year 2024, KABBEEK FARMA made a profit of €158,596.
- Where can I find the annual accounts of KABBEEK FARMA?
- KABBEEK FARMA filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.